Literature DB >> 31484599

Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team.

M Uchida, T Nakamura, H Watanabe, K Kato, T Miyamoto, K Akashi, S Masuda.   

Abstract

Patients receiving cancer chemotherapy may experience a number of potentially severe adverse drug reactions. It is crucial for all members of the health care team to monitor the effect of medicines on the patient to ensure the safety and efficacy of the chemotherapy. The present study prepared medication instruction sheets (MISs) on hematological malignancy and conducted a questionnaire survey to verify their usefulness among physicians, dentists, and nurses. MISs were prepared for 103 chemotherapy and 44 pretreatment regimens for hematopoietic stem cell transplantation in the Department of Hematology at Kyushu University Hospital. Eight questions were prepared to investigate whether MISs could help physicians, dentists, and nurses manage cancer chemotherapy more safely, effectively, and efficiently, as well as in the sharing of information. A total of 35 medical staff working in inpatient wards, including 8 physicians, 3 dentists, and 24 nurses, participated in the questionnaire survey. All of the staff responded to the questionnaire survey, which showed that the MISs were favorably accepted by the participants. There was no negative opinion on the management of chemotherapy using the MISs. The MIS was a useful tool for sharing information on cancer chemotherapy between patients and medical staff and for enabling efficient management, thereby improving the safety and efficacy of treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31484599     DOI: 10.1691/ph.2019.9467

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

1.  Evaluation of Medication Instruction Sheets for Patients Undergoing R-CHOP Therapy in Non-Hodgkin's Lymphoma.

Authors:  Mayako Uchida; Rika Kawai; Rie Hisamitsu; Sayaka Mai; Shigeru Ishida; Hiroyuki Watanabe; Takehiro Kawashiri; Koji Kato; Keiko Hosohata; Toshihiro Miyamoto; Nobuaki Egashira; Tsutomu Nakamura; Koichi Akashi; Ichiro Ieiri
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.